Fecal microbiota transplantation for Clostridium difficile-associated colitis in a severely immunocompromized critically ill AIDS patient: A case report

AIDS

Volumn 28, Issue 5, 2014, Pages 798-799

  Schünemann, Marko ^b   Oette, Mark ^a  

^a Department of General Medicine Gastroenterology and Infectious Diseases Augustinerinnen Hospital   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACICLOVIR; ALLOPURINOL; BIPERIDEN; CALCITRIOL; CASPOFUNGIN; CIPROFLOXACIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; DARUNAVIR; FIDAXOMICIN; LAMIVUDINE; LEVOTHYROXINE; MEROPENEM; METRONIDAZOLE; MIRTAZAPINE; OLANZAPINE; PROPRANOLOL; RITONAVIR; TIGECYCLINE; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGRANULOCYTOSIS; AIDS PATIENT; ANTIVIRAL THERAPY; ASCITES FLUID; ASPIRATION PNEUMONIA; CANDIDA ALBICANS; CANDIDA GLABRATA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; ENCEPHALITIS; ESOPHAGITIS; ESOPHAGUS BIOPSY; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; GIARDIASIS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPROMISED PATIENT; KIDNEY FAILURE; LETTER; MALE; METABOLIC ACIDOSIS; MIDDLE AGED; PARALYTIC ILEUS; PERITONITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCTITIS; PSEUDOMEMBRANOUS COLITIS; PSEUDOMONAS AERUGINOSA; PSORIASIS; PSYCHOSIS; SEPTICEMIA; STOMATITIS; STREPTOCOCCUS PARASANGUINIS; TOXIC MEGACOLON; VANCOMYCIN RESISTANT ENTEROCOCCUS; VIRUS LOAD; WASTING SYNDROME; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOLOGICAL THERAPY; CLOSTRIDIUM INFECTIONS; COLITIS; COMPLICATION; CRITICAL ILLNESS; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS; CRITICAL ILLNESS; FECES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84898750021     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000148     Document Type: Letter

References (4)

1. Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, et al. OPT-80-004 Clinical Study Group. Fidaxomycin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, noninferiority, randomized controlled trial. Lancet Infect Dies 2012; 12:281-289.
2. Rohlke F, Stollmann N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Ther Adv Gastroenterol 2012; 5:403-420.
3. Kleger A, Schnell J, Essig A, Wagner M, Bommer M, Seufferlein T, et al. Case report: fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int 2013; 110:108-115.
4. Haines CF, Moore RD, Bartlett JG, Sears CL, Cosgrove SE, Caroll K, et al. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS 2013; 27:2799-2807.